Tags

Type your tag names separated by a space and hit enter

Carbon monoxide exposures in Australian workplaces could precipitate myocardial ischaemia in smoking workers with coronary artery disease.
Aust N Z J Public Health. 1998; 22(3 Suppl):389-93.AN

Abstract

BACKGROUND

Quite low levels of carbon monoxide (CO) exposure have been shown experimentally to induce myocardial ischaemia in subjects with coronary artery disease. This study examines the actual exposure levels in Australian workplaces under normal operating conditions, to assess whether the resulting carboxyhaemoglobin (COHb) levels are high enough to present a risk of myocardial ischaemia in any workers who may have recognised or unrecognised coronary artery disease.

METHODS

A total of 84 workers took part in the study, 60 of whom were working in an environment where a combustion process was taking place indoors and were therefore classified as exposed to CO. Ambient CO levels and end-expiratory CO levels (the latter as a predictor of COHb) were measured two-hourly and the number of cigarettes smoked over an eight-hour shift recorded.

RESULTS

Mean workplace CO levels throughout the shift ranged between three and 12 ppm. Mean COHb ranged between 0.7% and 2.1% in non-smokers and 2.1%-7.6% in smokers, except for a single reading of 12.5% in forklift operations (one smoker). Exposed workers had significantly higher COHb levels than the non-exposed, both for smokers and non-smokers. Smoking also had an important independent effect on COHb.

CONCLUSION

Under workplace conditions prevailing in industries where combustion processes are occurring indoors, CO exposures are unlikely to be high enough to cause myocardial ischaemia in non-smokers. However in a worker whose COHb is already raised from smoking, an increment from such occupational environments could be sufficient to induce myocardial ischaemia in workers with coronary artery disease.

Authors+Show Affiliations

Department of Public Health, University of Adelaide, South Australia.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9629828

Citation

Wickramatillake, H D., et al. "Carbon Monoxide Exposures in Australian Workplaces Could Precipitate Myocardial Ischaemia in Smoking Workers With Coronary Artery Disease." Australian and New Zealand Journal of Public Health, vol. 22, no. 3 Suppl, 1998, pp. 389-93.
Wickramatillake HD, Gun RT, Ryan P. Carbon monoxide exposures in Australian workplaces could precipitate myocardial ischaemia in smoking workers with coronary artery disease. Aust N Z J Public Health. 1998;22(3 Suppl):389-93.
Wickramatillake, H. D., Gun, R. T., & Ryan, P. (1998). Carbon monoxide exposures in Australian workplaces could precipitate myocardial ischaemia in smoking workers with coronary artery disease. Australian and New Zealand Journal of Public Health, 22(3 Suppl), 389-93.
Wickramatillake HD, Gun RT, Ryan P. Carbon Monoxide Exposures in Australian Workplaces Could Precipitate Myocardial Ischaemia in Smoking Workers With Coronary Artery Disease. Aust N Z J Public Health. 1998;22(3 Suppl):389-93. PubMed PMID: 9629828.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Carbon monoxide exposures in Australian workplaces could precipitate myocardial ischaemia in smoking workers with coronary artery disease. AU - Wickramatillake,H D, AU - Gun,R T, AU - Ryan,P, PY - 1998/6/18/pubmed PY - 1998/6/18/medline PY - 1998/6/18/entrez SP - 389 EP - 93 JF - Australian and New Zealand journal of public health JO - Aust N Z J Public Health VL - 22 IS - 3 Suppl N2 - BACKGROUND: Quite low levels of carbon monoxide (CO) exposure have been shown experimentally to induce myocardial ischaemia in subjects with coronary artery disease. This study examines the actual exposure levels in Australian workplaces under normal operating conditions, to assess whether the resulting carboxyhaemoglobin (COHb) levels are high enough to present a risk of myocardial ischaemia in any workers who may have recognised or unrecognised coronary artery disease. METHODS: A total of 84 workers took part in the study, 60 of whom were working in an environment where a combustion process was taking place indoors and were therefore classified as exposed to CO. Ambient CO levels and end-expiratory CO levels (the latter as a predictor of COHb) were measured two-hourly and the number of cigarettes smoked over an eight-hour shift recorded. RESULTS: Mean workplace CO levels throughout the shift ranged between three and 12 ppm. Mean COHb ranged between 0.7% and 2.1% in non-smokers and 2.1%-7.6% in smokers, except for a single reading of 12.5% in forklift operations (one smoker). Exposed workers had significantly higher COHb levels than the non-exposed, both for smokers and non-smokers. Smoking also had an important independent effect on COHb. CONCLUSION: Under workplace conditions prevailing in industries where combustion processes are occurring indoors, CO exposures are unlikely to be high enough to cause myocardial ischaemia in non-smokers. However in a worker whose COHb is already raised from smoking, an increment from such occupational environments could be sufficient to induce myocardial ischaemia in workers with coronary artery disease. SN - 1326-0200 UR - https://www.unboundmedicine.com/medline/citation/9629828/Carbon_monoxide_exposures_in_Australian_workplaces_could_precipitate_myocardial_ischaemia_in_smoking_workers_with_coronary_artery_disease_ DB - PRIME DP - Unbound Medicine ER -